Jessi Gold, MD, MS, is an Assistant Professor and the Director of Wellness, Engagement, and Outreach in the Department of Psychiatry at Washington University School of Medicine in Saint Louis. She is a nationally recognized expert on healthcare worker mental health and burnout (particularly during the pandemic), college mental health, using social media and media for mental health advocacy, and the overlap between pop culture and mental health, including celebrity self-disclosure. Dr. Gold is a graduate of the University of Pennsylvania with a B.A.

Dr. Nick Jacobson is an assistant professor in the departments of Biomedical Data Science, Psychiatry, and Computer Science within the Center for Technology and Behavioral Health in the Geisel School of Medicine at Dartmouth College. He directs the AI and Mental Health: Innovation in Technology Guided Healthcare (AIM HIGH) Laboratory. Dr. Jacobson researches the use of technology to enhance both the assessment and treatment of anxiety and depression.

Emily Bernstein completed her doctorate in clinical psychology at Harvard University and is now a Hope Fellow in psychology with the Center for OCD and Related Disorders (CORD) at Massachusetts General Hospital and Harvard Medical School. Her research centers on transdiagnostic mechanisms in the development and treatment of emotional disorders. Her work focuses on identifying modifiable causal mechanisms contributing to emotion dysregulation and developing novel interventions (e.g., brief interventions, digital tools, and health behaviors) to target these processes.

Rachel Yehuda, PhD, is an Endowed Professor of Psychiatry and Neuroscience of Trauma.  She is also Director of Mental Health at the James J. Peters Veterans Affairs Medical Center. Dr. Yehuda is a recognized leader in the field of traumatic stress studies, PTSD, and intergenerational trauma.  In 2019, Dr. Yehuda was elected to the National Academy of Medicine for her seminal contributions to understanding the psychological and biological impact of traumatic stress.  In 2020, Dr.

Dr. Stephen Ross is Research Associate Professor of Psychiatry and Child & Adolescent Psychiatry at the NYU Grossman School of Medicine. Dr. Ross is a founding member of the NYU Psychedelic Research Group and is currently associate director of the NYU Langone Health (NYULH) Center for Psychedelic Medicine and director of the NYULH Psychedelic Medicine Research Training Program. In 21 years at NYU and Bellevue, Dr Ross has been involved in a variety of leadership roles in administration, teaching and research.

Robin Carhart-Harris, PhD is the Ralph Metzner Distinguished Professor in Neurology and Psychiatry and Director Neuroscape’s Psychedelics Division at the University of California, San Francisco. He moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol. Robin has designed human brain imaging studies with LSD, psilocybin, MDMA and DMT, and clinical trials of psilocybin therapy for severe mental illnesses. He has authored over 130 papers, with over forteen thousand citations.

Ashley Bramhall earned her Master of Arts in Clinical Psychology from Pepperdine University, and as an MFT Trainee, Ashley began her training and specialization in the treatment of anxiety & OC spectrum disorders at Renewed Freedom Foundation. She continued to build on this expertise with specializations in children, teens, and athletes as an AMFT at Renewed Freedom Center for Rapid Anxiety Relief.